Articles tagged "Graft survival"

2017 American Transplant Congress
Outcomes of Deceased Donor Kidney Transplantation in Elderly Recipients Aged 70 Years and Older.
A. Adamusiak,¹ T. Salter,² P. Andrews,² C. Callaghan.¹
¹Department of Nephrology and Transplantation, Guy's Hospital, London, United Kingdom; ²Department of Nephrology, St Helier Hospital, London, United Kingdom
Introduction: The number of patients aged 70 years and older receiving renal replacement therapy is increasing. There is uncertainty regarding whether listing for deceased donor…
2017 American Transplant Congress
Using Scheduled Commercial Flights for Transport of Liver for Transplant.
V. Gupta,¹ A. Chandra,¹ M. Singh,¹ V. Gupta,¹ S. Kumar,¹ P. Joshi,¹ P. Sharma,² H. Hasan,³ P. Srivastava,⁴ M. Khan,¹ Z. Arshad,¹ R. Kant.¹
¹King George's Medical University, Lucknow, Uttar Pradesh, India; ²Uttar Pradesh Chief Minister Office, Lucknow, Uttar Pradesh, India; ³Traffic Directorate, Lucknow, Uttar Pradesh, India; ⁴Airport Director, Amausi Airport, Airports Authority of India, Lucknow, Uttar Pradesh, India
Transport of liver procured from a brain dead donor (BDD) to the receiving hospital by chartered private flight (PF) is a costly endeavour. Also the…
2017 American Transplant Congress
Long-Term Outcomes Among Slow versus Delayed or Immediate Graft Function Kidney Transplant Recipients: A Single-Center Experience.
I. Bajjoka, A. Yaldo, C. Crombez, M. Abouljoud.
Transplant Institute, Henry Ford Health System, Detroit, MI
Purpose: To compare and evaluate short and long-term outcomes for kidney transplant recipients (KTR) with slow graft function (SGF) versus delayed (DGF) or immediate (IGF)…
2017 American Transplant Congress
CD4⁺/CD8⁺ T Cell Ratio as a Predictive Marker for Early Graft Failure in Pig to Non-Human Primate Islet Xenotransplantation with Immunosuppression.
S. Choi,^1,3,4 H.-J. Kim,^1,2,3,4 I.-H. Yoon,^1,2 J.-S. Kim,^1,2,6 S.-J. Kang,^1,2,3,4 H.-Y. Nam,^1,2 B.-H. Min,¹ J.-S. Shin,^1,6 J.-M. Kim,^1,6 Y.-H. Kim,^1,5 W.-W. Lee,^1,2,3,4 C.-G. Park.^1,2,3,4,6
¹Xenotransplantation Research Center, Seoul National University College of Medicine, Seoul, Korea; ²Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; ³Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Korea; ⁴Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea; ⁵Department of Microbiology, Kyungpook National University School of Medicine, Daegu, Korea; ⁶Institute of Endemic Diseases, Seoul National University College of Medicine, Seoul, Korea
Background: Outstanding results from nonhuman primate study put islet xenotransplantation with immunosuppression closer to the clinical application. To establish successful immune suppressive protocols, immune monitoring…
2017 American Transplant Congress
Is It Safe to Use Older Donor Liver Grafts for Older Recipients?
M. Safwan, K. Collins, K. Takahashi, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai.
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
Aim: The safety of liver transplantation (LT) using older donor grafts into older recipients remains to be elucidated. The aim of this study was to…
2017 American Transplant Congress
Muscle Mass Is Predictive of Mortality in Obese Renal Transplant Patients.
J. Souweine,^1,3 M. Le Quintrec,¹ I. Szwarc,¹ V. Pernin,¹ G. Mourad,¹ J. Cristol,^2,3 J. Serre.¹
¹Nephrology, University Hospital of Montpellier, Montpellier, France; ²Biochemistry, University Hospital of Montpellier, Montpellier, France; ³PhyMedExp, UMR CNRS 9214, INSERM U1046, University Hospital of Montpellier, Montpellier, France
Introduction: The impact of obesity (body mass index [BMI] > 30 kg/m[sup2]) on kidney allograft outcomes is controversial. Recent studies found that obesity does not…
2017 American Transplant Congress
Comparing Renal Function Recovery and Long Term Outcomes in Recipients of Standard and Expanded Criteria Donor Kidney Transplants.
S. Sandal, M. Cantarovich, S. Paraskevas, N. Almaghrawi, P. Chaudhury, J. Tchervenkov.
McGill University Health Center, Montreal, Canada
Several donor and recipient characteristics are associated with adverse kidney transplantation (KT) outcomes. Our group has previously shown that based on the donor's terminal creatinine,…
2017 American Transplant Congress
Anti-Angiotensin Type 1 Receptor Antibodies Associate with Rejection in Simultaneous Pancreas and Kidney Transplant and Pancreas Transplant Alone Recipients.
A. Peng, D. Dafoe, J. Choi, A. Vo, X. Zhang, R. Najjar, E. Huang, S. Jordan.
Comprehensive Transplant Center, Cedars Sinai Medical Center, Los Angeles, CA
Background: Anti-angiotensin type 1 receptor antibodies (AT1R Ab) have been found to have a strong association with antibody mediated rejection (Reinsmoen et al, Transpl 2010;…
2017 American Transplant Congress
Impact of Type of Recipient Diabetes on 1 and 3-Year Kidney Allograft and Patient Outcomes.
S. Kim, F. Wu, D. Cibrik, Y. Li, A. Naik.
University of Michigan, Ann Arbor
The pathophysiology of type 1 (T1DM) and type 2 (T2DM) diabetes is different and has been conjectured to impact transplantation outcomes differently over time especially…
2017 American Transplant Congress
Results of Biliary Reconstruction with PTFE Graft in Liver Transplantation.
E. Ayvazoglu Soy,¹ G. Moray,¹ A. Torgay,² H. Ozdemir,³ M. Haberal.¹
¹General Surgery and Transplantation, Baskent University, Ankara, Turkey; ²Anesthesiology, Baskent University, Ankara, Turkey; ³Pathology, Baskent University, Ankara, Turkey
Introduction: Biliary complications are often referred to as the 'Achilles heel' of liver transplantation (LT) with their high incidence rate, the need for repeated and…